Epidurolysis is a Promising Treatment for Stage I-II Lumbar Disc Herniation at the Three-Month Follow-Up
Lumina : Indonesian Journal of Neurology · 30.04.2026 · 2 (1) · 1-11
DOI: 10.19166/lijn.v2i1.10738 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lumina : Indonesian Journal of Neurology, online erschienen am 30.04.2026. Verfasst von Trianggoro Budisulistyo.
Abstract (Originalsprache)
Introduction
About 90% of patients with lumbar disc herniation (LDH) improve with conservative treatment, while 10–19% require surgery. Epidural steroid injection (ESI) with local anesthetic provides pain relief for up to 6 months (30–40%) and up to 1 year (68.5%). Epidurolysis, using 1500 units of hyaluronidase before ESI, is often applied in patients who continue to experience pain after spinal surgery. This study compares pain intensity and activities of daily living (ADL) in Stage I–II LDH patients treated with either epidurolysis or ESI.
Methods
This experimental study used a pre- and post-test control group design. Patients with Stage I–II LDH at Dr. Kariadi Hospital, Semarang, were divided into two groups: epidurolysis and ESI. NRS, Pain DETECT, and ODI scores were evaluated before treatment, at Week 3, and at Month 3, then compared across observation times.
Results
From January to August 2022, 161 patients met the inclusion criteria: 84 received epidurolysis and 77 received ESI. Eighteen participants dropped out. Significant improvements in NRS, Pain DETECT, and ODI scores were observed up to Month 3 (p < 0.05). The epidurolysis group showed greater improvement, with lower NRS (1.21 ± 0.50 vs 1.51 ± 0.53), Pain DETECT (8.61 ± 2.66 vs 12.17 ± 2.78), and ODI (4.72 ± 3.34 vs 8.51 ± 3.67) scores. Demographic factors had no significant effect on ADL changes.
Conclusion
Hyaluronidase reduces fibrosis and edema, enhances triamcinolone absorption, and may improve nerve recovery. Adding 1500 units of hyaluronidase before ESI results in better pain relief and functional outcomes in Stage I–II chronic LDH patients. Keywords: Stage I-II LDH, Triamcinolone, Hyaluronidase, NRS, Pain DETECT, ODI
Zitieren
APA
Budisulistyo, T. (2026). Epidurolysis is a Promising Treatment for Stage I-II Lumbar Disc Herniation at the Three-Month Follow-Up. Lumina : Indonesian Journal of Neurology, 2(1), 1-11. https://doi.org/10.19166/lijn.v2i1.10738
Vancouver
Budisulistyo T. Epidurolysis is a Promising Treatment for Stage I-II Lumbar Disc Herniation at the Three-Month Follow-Up. Lumina : Indonesian Journal of Neurology. 2026;2(1):1-11. doi:10.19166/lijn.v2i1.10738
BibTeX
@article{Budisulistyo2026,
author = {Budisulistyo, Trianggoro},
title = {Epidurolysis is a Promising Treatment for Stage I-II Lumbar Disc Herniation at the Three-Month Follow-Up},
journal = {Lumina : Indonesian Journal of Neurology},
year = {2026},
volume = {2},
number = {1},
pages = {1--11},
doi = {10.19166/lijn.v2i1.10738}
}
EUVIMED